Moneycontrol PRO
HomeNewsUsd 500 million

Usd 500 Million

Jump to
  • SBI hits overseas debt market with $500 mn 5-year bond sale

    The nation's largest lender State Bank of India has hit the international debt market with a benchmark issue to raise around USD 500 million as part of its USD 10-billion medium-term notes programme through a five- year dollar money sale.

  • World Bank approves USD 500 m loan for Indian MSMEs

    The Project will support MSMEs through direct financing by the Small Industries Development Bank of India (SIDBI) and Participating Financial Institutions (PFIs) across three components.

  • Infosys signs $500 mn deal with British Petroleum

    This deal, a five year group wide supplier agreement, also marks BP's return into outsourcing and hushes all talk of the company slashing down on work with Infosys.

  • GMR gets respite in Male Airport issue

    The anti-corruption committee in Maldives has said that no elements of corruption went into the award of the Male airport contract that was awarded to GMR for the expansion of the existing airport.

  • Shapoorji Pallonji not to enter realty PE space

    Shapoorji Pallonji one of the country's largest developers, has called off its plans to foray into the real estate private equity space, as the company has not been able to raise a corpus of USD 500 million due to a conflict of interest.

  • Ranbaxy pleads guilty to felony; agrees to pay USD 500m

    In a settlement with the US FDA at the US department of Justice, Ranbaxy has pleaded guilty to felony charges. This is a culmination of the consent degree that the company had signed in end-2011 with the US Food and Drug Administration.

  • Tough for Ranbaxy to revive US biz now: Antique

    Pharama analyst, Anmol Ganjoo beleives that acceptence of this felony charges will not only be sentiment negative for Ranbaxy but it will hit their brand name too.

  • Ranbaxy shrs fall on USD 500mn US lawsuits settlement

    Ranbaxy said its US arm is pleading guilty to criminal charges related to violation of the Food, Drugs and Cosmetics Act and the company. owned by Japan's Daiichi Sankyo, will now pay USD 500 million to settle all the civil, criminal lawsuits.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347